Trials / Conditions / Neovascular Glaucoma

Neovascular Glaucoma

20 registered clinical trials studyying Neovascular Glaucoma — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Minimally Invasive Suprachoroidal Drainage for the Treatment of Neovascular Glaucoma NCT07201415	Zhongnan Hospital	N/A
Active Not Recruiting	Effect of Subconjunctival 5-fluorouracil on the Outcome of Ahmed Valve in Neovascular Glaucoma NCT05316142	Iran University of Medical Sciences	N/A
Completed	A Study on the Treatment Strategy of NVG Secondary to PDR NCT05156021	Ruijin Hospital	N/A
Active Not Recruiting	KDR2-2 Suspension Eyedrop in the Treatment of Neovascular Glaucoma (KDR-NVG) Trial NCT04844619	Sun Yat-sen University	Phase 1
Recruiting	Study to Learn More About Safety of Aflibercept Injection in Japanese Patients With Neovascular Glaucoma (NVG) NCT04519619	Bayer	—
Completed	Aflibercept as Adjunctive Treatment for Filtration Surgery in Neovascular Glaucoma NCT04970251	Siriraj Hospital	N/A
Completed	Clinical Characteristics of Neovascular Glaucoma NCT07177807	Zhongnan Hospital	—
Completed	The Effect of Conbercept Injection Through Different Routes for Neovascular Glaucoma NCT03154892	Second Affiliated Hospital of Xi'an Jiaotong University	N/A
Unknown	Trial of Aganirsen in iCRVO Patients at Risk of Developing NVG NCT02947867	Gene Signal SAS	Phase 2 / Phase 3
Completed	Ahmed Glaucoma Valve Surgery With Mitomycin-C NCT02805257	University of California, San Francisco	Phase 2
Unknown	Analysis of Aqueous and Vitreous Humor NCT02067013	California Retina Consultants	Phase 2
Completed	Use of Intravitreal Aflibercept Injection for Neovascular Glaucoma NCT01711879	University of Colorado, Denver	N/A
Terminated	Comparative Study, Safety and Efficacy, Ahmed Glaucoma Drainage Device, Model M4 Model S2 in Neovascular Glauc NCT02260219	Asociación para Evitar la Ceguera en México	N/A
Terminated	Patch Graft Material Safety and Effectiveness in Covering Glaucoma Drainage Device Tube NCT01301378	Wills Eye	N/A
Completed	Study to Evaluate the Effects of Ranibizumab (Lucentis) for Patients With Rubeosis and Neovascular Glaucoma NCT01370135	University of Luebeck	N/A
Withdrawn	Lucentis for New Onset Neovascular Glaucoma NCT00727038	University of Illinois at Chicago	Phase 1 / Phase 2
Withdrawn	Effects of Travoprost on Neovascular Glaucoma NCT00441181	Federal University of São Paulo	N/A
Completed	Oculusgen (Ologen) Glaucoma MMC Control in Estonia NCT00524758	Pro Top & Mediking Company Limited	Phase 3
Completed	Avastin as an Adjunct to Diode Laser in the Treatment of Neovascular Glaucoma NCT01051583	Cairo University	Phase 2
Unknown	Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves With and Without Intravitreal Triamcinolone Inje NCT00491712	Federal University of São Paulo	N/A